Boston Scientific CorporationBSXNYSE
Loading
Cost of Revenue Over TimeStrong
Percentile Rank93
3Y CAGR+7.8%
5Y CAGR+7.5%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+7.8%/yr
vs +10.4%/yr prior
5Y CAGR
+7.5%/yr
Consistent
Acceleration
-2.6pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.22B | -4.0% |
| 2024 | $6.48B | +19.8% |
| 2023 | $5.41B | +8.9% |
| 2022 | $4.97B | +12.2% |
| 2021 | $4.43B | +2.1% |
| 2020 | $4.34B | +12.5% |
| 2019 | $3.86B | +15.2% |
| 2018 | $3.35B | +5.3% |
| 2017 | $3.18B | +4.4% |
| 2016 | $3.04B | - |